Reduced Anti-Histone Antibodies and Increased Risk of Rheumatoid Arthritis Associated with a Single Nucleotide Polymorphism in PADI4 in North Americans.


Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Jun 2019
Historique:
received: 20 05 2019
revised: 20 06 2019
accepted: 21 06 2019
entrez: 28 6 2019
pubmed: 28 6 2019
medline: 18 12 2019
Statut: epublish

Résumé

Autoantibodies against citrullinated proteins are a hallmark of rheumatoid arthritis, a destructive inflammatory arthritis. Peptidylarginine deiminase 4 (PAD4) has been hypothesized to contribute to rheumatoid arthritis by citrullinating histones to induce neutrophil extracellular traps (NETs), which display citrullinated proteins that are targeted by autoantibodies to drive inflammation and arthritis. Consistent with this theory, PAD4-deficient mice have reduced NETs, autoantibodies, and arthritis. However, PAD4's role in human rheumatoid arthritis is less clear. Here, we determine if single nucleotide polymorphism rs2240335 in

Identifiants

pubmed: 31242568
pii: ijms20123093
doi: 10.3390/ijms20123093
pmc: PMC6627847
pii:
doi:

Substances chimiques

Autoantibodies 0
Autoantigens 0
Histones 0
Immunoglobulin G 0
PADI4 protein, human EC 3.5.3.15
Protein-Arginine Deiminase Type 4 EC 3.5.3.15

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : Doris Duke Charitable Foundation
ID : 2015099
Pays : United States
Organisme : NIH HHS
ID : T32HL07899
Pays : United States
Organisme : NHLBI NIH HHS
ID : T32 HL007899
Pays : United States
Organisme : NIAMS NIH HHS
ID : K08 AR065500
Pays : United States
Organisme : NIH HHS
ID : K08AR065500
Pays : United States
Organisme : University of Wisconsin School of Medicine and Public Health from the Wisconsin Partnership Program
ID : N/A

Références

J Biol Chem. 2002 Dec 20;277(51):49562-8
pubmed: 12393868
Nat Genet. 2003 Aug;34(4):395-402
pubmed: 12833157
Ann Rheum Dis. 2004 Apr;63(4):373-81
pubmed: 15020330
Cell. 2004 Sep 3;118(5):545-53
pubmed: 15339660
Science. 2004 Oct 8;306(5694):279-83
pubmed: 15345777
Mol Cell Biol. 2008 Aug;28(15):4745-58
pubmed: 18505818
J Cell Biol. 2009 Jan 26;184(2):205-13
pubmed: 19153223
Immunol Rev. 2010 Jan;233(1):34-54
pubmed: 20192991
J Exp Med. 2010 Aug 30;207(9):1853-62
pubmed: 20733033
Ann Rheum Dis. 2011 Jan;70(1):188-93
pubmed: 20736390
Cell Host Microbe. 2010 Nov 18;8(5):445-54
pubmed: 21075355
Arthritis Rheum. 2011 Mar;63(3):633-9
pubmed: 21360492
Arthritis Rheum. 2011 Apr;63(4):884-93
pubmed: 21452313
Hum Mol Genet. 2011 Jul 1;20(13):2680-5
pubmed: 21505073
PLoS One. 2012;7(5):e35296
pubmed: 22662108
Scand J Rheumatol. 2012;41(6):426-33
pubmed: 22985259
Front Immunol. 2013 Feb 20;4:38
pubmed: 23430963
Sci Transl Med. 2013 Mar 27;5(178):178ra40
pubmed: 23536012
Int Arch Allergy Appl Immunol. 1990;91(3):297-305
pubmed: 2354871
Nat Commun. 2013;4:1836
pubmed: 23673621
Ann Rheum Dis. 2014 Jul;73(7):1414-22
pubmed: 23727635
Arthritis Rheumatol. 2014 Jun;66(6):1482-91
pubmed: 24497204
Arthritis Res Ther. 2014 Jun 13;16(3):R122
pubmed: 24928093
Arthritis Rheumatol. 2015 Nov;67(11):2990-3003
pubmed: 26097119
Nat Commun. 2015 Jul 07;6:7545
pubmed: 26151758
Ann Rheum Dis. 2016 Oct;75(10):1866-75
pubmed: 26659717
Nat Commun. 2016 Mar 11;7:10973
pubmed: 26964500
BMC Musculoskelet Disord. 2016 May 05;17:205
pubmed: 27150598
Arthritis Res Ther. 2016 Jul 22;18(1):173
pubmed: 27450561
Front Immunol. 2016 Nov 14;7:485
pubmed: 27895639
Front Immunol. 2017 Jan 13;7:671
pubmed: 28133459
J Autoimmun. 2017 Jun;80:39-47
pubmed: 28188029
J Bone Miner Res. 2017 Aug;32(8):1681-1691
pubmed: 28425620
Biol Proced Online. 2018 Apr 1;20:7
pubmed: 29618953
Arch Immunol Ther Exp (Warsz). 2018 Oct;66(5):379-388
pubmed: 29713726
Front Immunol. 2018 May 29;9:1182
pubmed: 29896200
Arthritis Rheumatol. 2018 Dec;70(12):1933-1945
pubmed: 29927106
J Immunol. 2018 Aug 15;201(4):1241-1252
pubmed: 29987161
Front Immunol. 2018 Jul 09;9:1573
pubmed: 30038623
Arthritis Rheumatol. 2019 Feb;71(2):196-209
pubmed: 30152202
PLoS One. 2018 Aug 30;13(8):e0203214
pubmed: 30161253
Front Immunol. 2018 Sep 18;9:2036
pubmed: 30279690
Front Immunol. 2019 Jan 04;9:3033
pubmed: 30662440
J Immunol Res. 2019 Mar 12;2019:2160192
pubmed: 30993117
PLoS One. 2019 May 28;14(5):e0217221
pubmed: 31136605
Arthritis Rheum. 1997 Sep;40(9):1594-600
pubmed: 9324013

Auteurs

Aisha M Mergaert (AM)

Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. mergaert@wisc.edu.
Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. mergaert@wisc.edu.

Mandar Bawadekar (M)

Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. mandar.bawadekar@gmail.com.

Thai Q Nguyen (TQ)

Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. nguyen45@wisc.edu.

Laura Massarenti (L)

Institute for Inflammation Research, Center for Rheumatology and Spine Diseases, Copenhagen University Hospital, Rigshospitalet, DK-2100 Copenhagen, Denmark. laura.massarenti@regionh.dk.

Caitlyn L Holmes (CL)

Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. cherndon@medicine.wisc.edu.
Department of Pathology and Laboratory Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. cherndon@medicine.wisc.edu.

Ryan Rebernick (R)

Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. reberya@gmail.com.

Steven J Schrodi (SJ)

Center for Precision Medicine Research, Marshfield Clinic Research Institute, Marshfield, WI 54449, USA. schrodi.steven@marshfieldresearch.org.

Miriam A Shelef (MA)

Department of Medicine, University of Wisconsin-Madison, Madison, WI 53705, USA. mshelef@medicine.wisc.edu.
William S. Middleton Memorial Veterans Hospital, Madison, WI 53705, USA. mshelef@medicine.wisc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH